Publication | Open Access
DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts
13
Citations
20
References
2022
Year
In conclusion, our findings support for DACT2 as a novel pharmacological target for pulmonary fibrosis treatments.
| Year | Citations | |
|---|---|---|
Page 1
Page 1